[Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
Fang
F
F
Huang
M
M
D002064:Buserelin / Q000009:adverse effects* / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy*; D004958:Estradiol / Q000172:deficiency; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects / Q000627:therapeutic use; D017274:Nafarelin / Q000009:adverse effects / Q000627:therapeutic use; D010024:Osteoporosis / Q000209:etiology* / Q000517:prevention & control
D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D016729:Leuprolide; D002064:Buserelin